骨粗鬆症治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00004071
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

市場概要

骨粗鬆症は、人々が罹患する病状であり、骨密度と骨の質の低下を特徴とします。さらに、この病状では骨が多孔質になり、よりもろくなり、骨折しやすくなります。この障害は、過剰な量の副甲状腺ホルモンによって引き起こされます。この状態は重度の骨折を引き起こす可能性があり、患者の健康に害を及ぼす可能性があります。その結果、この状態には骨粗鬆症薬の投与などの治療が必要になります。市場で入手可能な骨粗鬆症の治療薬には、副甲状腺ホルモン療法、カルシトニン、ビスホスホネート選択的エストロゲン阻害剤モジュレーター (SERM)、RANK リガンド阻害剤などがあります。これらの薬剤は、経口経路や静脈内経路など、さまざまな経路で体内に投与されます。

市場範囲

「2028 年までの世界の骨粗鬆症治療市場分析」は、世界市場の傾向分析に特に焦点を当てたヘルスケア業界の専門的で詳細な調査です。このレポートは、薬剤の種類、投与経路、流通チャネルごとに詳細な市場分割を行い、骨粗鬆症治療市場の概要を提供することを目的としています。このレポートは、骨粗鬆症治療市場の主要企業の市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション

    • 薬剤の種類に基づいて、市場はカルシトニン、ビスホスホネート、選択的エストロゲン受容体モジュレーター(SERM)、ランクリガンド(RANKL)阻害剤、副甲状腺ホルモン関連タンパク質(PTHrP)アナログなどに分類されます。 • 投与経路に基づいて、市場は経口、注射などに分類されます。 • 流通チャネルに基づいて、市場は病院、小売薬局、オンライン薬局に分類されます。

市場力学

要因:

    • 世界中で骨粗鬆症の有病率が増加しています。 • 世界中で高齢者人口が増加し、座りっぱなしのライフスタイルが採用されています。 • 高齢、不健康なライフスタイル、喫煙、アルコール依存症、併存疾患などの危険因子。 • 骨粗鬆症の治療と病気の効果的な管理についての意識が高まります。 • 骨粗鬆症治療のための治療薬の強力なパイプラインの存在。

拘束:

    • しかし、長期にわたる治療や時間のかかる製品承認手続きによる副作用により、市場の成長が抑制されることが予想されます。

地域的枠組み

このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2019 年から 2028 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南米。各地域による骨粗鬆症治療市場は、後にそれぞれの国とセグメントごとにサブセグメント化されます。このレポートでは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会について取り上げています。レポートは、需要と供給の両方の側面から市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南米では、これらの地域の骨粗鬆症治療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。

骨粗鬆症治療市場に対する新型コロナウイルス感染症 (COVID-19) の影響

新型コロナウイルス感染症 (COVID-19) は、2019 年 12 月に初めて武漢 (中国) で発生し、それ以来、速いペースで世界中に広がりました。米国、インド、ブラジル、ロシア、フランス、英国、トルコ、イタリア、スペインは、感染者数と死亡報告数で最も深刻な影響を受けている国の一部です。新型コロナウイルス感染症は、ロックダウン、渡航禁止、事業停止などにより、さまざまな国の経済や産業に影響を与えています。さまざまな工場や工場の閉鎖は世界のサプライチェーンに影響を及ぼし、世界市場での製品の製造、納期スケジュール、販売に悪影響を及ぼしています。製品納期の遅延や自社製品の将来の売上不振の可能性をすでに発表している企業はほとんどない。現在の市場状況に応じて、レポートは新型コロナウイルス感染症のパンデミックが市場全体に及ぼす現在および将来の影響をさらに評価し、より信頼性の高い本物の予測を提供しています。これに加えて、ヨーロッパ、アジア諸国が課している世界的な渡航禁止措置も影響しています。太平洋地域と北米は、ビジネスコラボレーションやパートナーシップの機会に影響を与えています。

市場関係者

このレポートでは、有機的および無機的な成長戦略として、骨粗鬆症治療市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、パートナーシップ、コラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。骨粗鬆症治療市場の支払者は、世界市場での骨粗鬆症治療の需要の高まりに伴い、将来的に有利な成長機会が得られると予想されています。レポートには、骨粗鬆症治療市場における主要企業のSWOT分析と市場戦略とともにプロフィールも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、企業概要、提供されるコンポーネント、サービス、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供します。 • テバ ファーマシューティカル インダストリーズ株式会社 • マイラン ネバダ州 •  Dr. Reddy's Laboratories Ltd • 武田薬品工業株式会社 •  F. ホフマン・ラ・ロッシュ株式会社 •  Radius Health, Inc. • グラクソ・スミスクライン社• ノバルティス AG • アムジェン社 • 旭化成ファーマ株式会社 Insight Partner の専任の研究分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の研究にさまざまなカスタマイズ オプションを提供しています。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the osteoporosis treatment market?

The global osteoporosis treatment market, Based on drug class, the osteoporosis treatment market is segmented into RANKL, bisphosphonates, selective estrogen receptor modulators (SERM), hormone therapies, and others. The RANKL segment held the largest osteoporosis treatment market share in 2023. However, the hormone therapies segment is predicted to register the highest CAGR during 2021–2031. Based on type, is bifurcated into primary osteoporosis and secondary osteoporosis. The primary osteoporosis segment held a larger market share in 2023 and is estimated to record a faster CAGR during 2023–2031. Based on end user, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest osteoporosis treatment market share in 2023 and is estimated to register the highest CAGR during the forecasted period.

What was the estimated osteoporosis treatment market size in 2023?

The osteoporosis treatment market was valued at US$ 16.83 billion in 2023.

What are the growth estimates for the osteoporosis treatment market till 2031?

The osteoporosis treatment market is expected to be valued at US$ 22.72 billion in 2031.

Who are the major players in the osteoporosis treatment market?

The osteoporosis treatment market majorly consists of the players such as Pfizer Inc.; Amgen Inc.; Cadila Pharmaceuticals; Eli Lilly and Company; Daiichi Sankyo Company, Limited; Teva Pharmaceuticals Inc.; Asahi Kasei Corporation; Novartis AG; Chugai Pharmaceutical Co., Ltd.; and Teijin Pharma Limited.

What is osteoporosis treatment?

The osteoporosis treatment includes various drugs and therapeutic modalities carefully developed to combat osteoporosis, a disease characterized by bones becoming brittle and prone to fractures. As osteoporosis is a progressive disease, initiating the treatment at an early stage can yield better results. Osteoporosis treatment involves a series of bone density tests to determine the mineral proportion in the bones. Depending on the severity of cases, osteoporosis treatment is suggested to help reduce pain, improve mobility, and reduce the risk of disability.

What are the driving factors for the osteoporosis treatment market?

The factors driving the growth of the osteoporosis treatment market include the increasing cases of osteoporosis due to modifications in lifestyle and growing awareness and diagnosis of osteoporosis.

The List of Companies - Osteoporosis Treatment Market

  1. Pfizer Inc.
  2. Amgen Inc.
  3. Cadila Pharmaceuticals
  4. Eli Lilly and Company
  5. Daiichi Sankyo Company, Limited
  6. Teva Pharmaceuticals Inc.
  7. Asahi Kasei Corporation
  8. Novartis AG
  9. Chugai Pharmaceutical Co., Ltd.
  10. Teijin Pharma Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports